Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,594Revenue $M201Net Margin (%)9.0Altman Z-Score-0.8
Enterprise Value $M1,423EPS $-0.4Operating Margin %21.7Piotroski F-Score6
P/E(ttm)72.6Beneish M-Score-1.5Pre-tax Margin (%)8.8Higher ROA y-yY
Price/Book20.610-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsN
Price/Sales5.45-y EBITDA Growth Rate %-28.7Current Ratio4.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)113Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NKTRFirst Eagle Investment 2011-12-31 Sold Out -0.003%$4.22 - $5.62
($4.9)
$ 12.12147%Sold Out0
NKTRFirst Eagle Investment 2011-09-30 Buy $4.98 - $7.65
($5.97)
$ 12.12103%New holding125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NKTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WANG SUSANDirector 2015-06-29Sell30,000$12.7-4.57 view
CHESS ROBERTDirector 2015-06-19Sell15,000$11.812.62 view
Lingnau LutzDirector 2015-06-15Sell25,000$11.158.7 view
KUEBLER CHRISTOPHER ADirector 2015-01-13Sell15,000$16-24.25 view
CHESS ROBERTDirector 2014-12-29Sell29,500$15.34-20.99 view
Thomsen Jillian B.SVP & Chief Accounting Officer 2014-12-22Sell5,000$15.56-22.11 view
Labrucherie Gil MSVP & General Counsel 2014-12-01Sell120,000$17.02-28.79 view
ROBIN HOWARD WPresident & CEO 2014-12-01Sell350,000$17.01-28.75 view
ROBIN HOWARD WPresident & CEO 2014-11-25Sell600,000$15.25-20.52 view
Labrucherie Gil MSVP & General Counsel 2014-11-24Sell10,500$15.04-19.41 view

Quarterly/Annual Reports about NKTR:

News about NKTR:

Articles On GuruFocus.com
Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 
cooldecency99 note on NKTR May 01 2010 
Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year Jan 06 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Nov 05 2009 

More From Other Websites
Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates Jun 24 2015
Columbia Pipeline to Join the S&P 500; Other Changes to S&P MidCap 400 & S&P SmallCap 600 Jun 24 2015
Biotech bargain bin Jun 19 2015
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 17 2015
Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for... Jun 02 2015
Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for... Jun 02 2015
bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top... May 28 2015
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2015 Global... May 28 2015
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2015 Global... May 28 2015
Biotech Fans Could Have a Hangover May 14 2015
Nektar Swings to Q1 Earnings, Updates 2015 Guidance - Analyst Blog May 04 2015
10-Q for Nektar Therapeutics May 03 2015
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report May 01 2015
Nektar tops Street 1Q forecasts Apr 30 2015
Nektar tops Street 1Q forecasts Apr 30 2015
Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 Apr 30 2015
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2015
Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today Apr 30 2015
Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 Apr 30 2015
Q1 2015 Nektar Therapeutics Earnings Release - After Market Close Apr 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK